PhD students
NAME |
YEAR |
RESEARCH TOPIC |
Annelot Baert |
2012-2017 |
From human genetics to radiobiology: in vitro radiosensitivity in individuals with a germline defect in DNA damage response genes |
2015-2018 |
Chromosomal radiosensitivity and instability of triple negative and/or young breast cancer and Fanconi anemia patients in South Africa (University of the Witwatersrand, South Africa) |
|
2014-2020 |
Zebrafish as a model to study DNA repair and developmental defects following loss of BRCA2 or ATM |
|
Master students (since 2014)
NAME |
YEAR |
STUDY PROGRAM |
RESEARCH TOPIC |
Lisa Baert |
2014 |
Bioscience Engineering |
Moleculair onderzoek in het kader van erfelijke borstkanker:evaluatie van de rol van ATM en kwantificatie van transcripten in BRCA1 |
Heidi Vandenhaute |
2014 |
Bioscience Engineering |
Moleculair onderzoek in het kader van erfelijke borstkanker |
Desirée Beyens |
2014 |
Industrial Sciences: Biochemistry |
Evaluatie van de prevalentie van ATM germinale mutaties in families met mannelijke borstkanker en detectie van varianten in niet-coderende regio’s van het BRCA1/2 gen |
Aurelie Giot |
2015 |
Bio-engineer |
Moleculair onderzoek van DNA repair genen in een patiënt met Bloom-like fenotype en in patiënten met een vermoedelijke erfelijke predispositie voor borstkanker |
Eline Meireson |
2015 |
Biomedical Sciences |
Moleculair onderzoek in een familie met autosomaal dominant polycytische nierziekte |
Jasmien Van Erdeghem |
2015 |
Biomedical Sciences |
Confidential |
Bram Verstraete |
2016 |
Bioscience Engineering |
Confidential |
Liesbeth Claeys |
2016 |
Biomedical Sciences |
Functionele studie van potentieel oncogene miRNA's in erfelijke borstkanker |
Nathalie Peeters |
2016 |
Biomedical Sciences |
The use of zebrafish as a model to analyze the pathogenicity of genetic variants in BRCA2 |
Karen Allart |
2017 |
Biomedical Sciences |
Functionele studie van niet-coderende RNAs in borstkanker |
Magali Buys |
2017 |
Bioscience Engineering |
Confidential |
Karen van Lint |
2017 |
Bio-engineer |
Develop an in vivo functional assay to determinate the pathogenicity of missense variants in breast cancer genes |
Guus Desloover |
2017 |
Industrial Sciences: Biochemistry |
Study of DNA repair pathways in BRCA2 and ATM deficient fish |
Coralie Wojciulewitsch |
2018 |
Bio-engineer |
Heading towards an in vivo functional assay for missense variants in breast cancer genes: developing functional readouts in the zebrafish model organism |
Jolien De Waele |
2018 |
Biomedical Sciences |
The use of zebrafish as a model to analyze the pathogenicity of variants in breast cancer genes |
Delfien Maetens |
2018 |
Biomedical Sciences |
Identification of germline mutations in familial pancreatic cancer patients and development of an accurate sequencing method for detection of somatic mutations in liquid biopsies of pancreatic cancer patients |
Arno Van de Voorde |
2019 |
Biomedical Sciences |
Pancreatic cancer: Genetic predisposition and liquid biopsies for detection and therapy monitoring |
Lies Van Der Steen |
2019 |
Biomedical Sciences |
The use of zebrafish as a model to analyse the pathogenic effect of variants in breast cancer genes |
Lore Dobbelaere |
2020 |
Biomedical Sciences |
Development of pancreatic cancer zebrafish xenografts for prediction individual |
Lore Desmet |
2020 |
Biomedical Sciences |
Pancreatic cancer : genetic predisposition & liquid biopsis |
Elyne de Neef |
2021 |
Biomedical Sciences |
Fishing for personalized treatment of pancreatic cancer patients using zebrafish xenographts |
Sarah Otte |
2021 |
Biomedical Sciences |
Search for genetic defects in DNA damage response genes in patients with Primary Immunodeficiency Diseases (PIDs) prone to develop cancer |
Lisa Faingnaert |
2021 |
Medicine |
Search for novel candidate genetic defects in PID patients |
Zineb Kamkam |
2021 |
Biomedical Sciences |
Prevalence of double somatic mismatch repair gene inactivation in carcinoma with Lynch characteristics but without germline mutations |
Frauke Boutte |
2022 |
Biomedical Sciences |
Biomedical Sciences Comparison of synergy between chemotherapeutic agents and PARP inhibitors in BRCA1 deficient and wildtype ovarian cancer cells using a zebrafish xenograft platform |
Robbe Decloedt |
2022 |
Biomedical Sciences |
Search for genetic defects in DNA damage response genes in patients with Primary Immunodeficiency Diseases (PIDs) prone to develop cancer |
Bachelor students (since 2016)
NAME |
YEAR |
STUDY PROGRAM |
RESEARCH TOPIC |
Bram Parton |
2016 |
FBT |
Moleculaire analyse van RECQL en kanker susceptibiliteitsgenen in families met een sterke predispositie voor borst- en ovariumkanker |
Jochen Dewitte |
2017 |
FBT |
Optimalisatie en validatie van targeted NGS als diagnostische test voor Hemochromatose en Homocystinuria |
Febe Windels |
2019 |
FBT |
Validatie van nieuwe combinatie therapiën in vitro en in vivo voor behandeling van eierstokkanker. |
Hélène Verhaege |
2019 |
FBT |
/ |
Pepijn Libbrecht |
2020 |
MLT |
/ |
Sebastiaan De Cooman |
2020 |
FBT |
De invloed van Olaparib op BRCAwt ovariumkankercellijnen SKOV3 en A2780 getest in vitro en in vivo met zebravis xenograft |
Alice Goethals |
2021 |
FBT |
Implementatie van digitale Multiplex Ligatie-afhankelijke Probe Amplificatie in een diagnostische setting |
Julie Van Tulden |
2022 |
FBT |
Optimalisatie van variantdetectie in tumorsupressorgenen met behulp van hybridisatie- gebaseerde NGS |